Boehringer Ingelheim India and NIPER Raebareli Sign MoU to Boost Pharma Education and Research
The MoU between NIPER Raebareli and Boehringer Ingelheim establishes a framework to strengthen academic and research collaboration in areas such as pharmaceutical technologies, novel drug delivery systems, joint research initiatives, academic exchange and capability-building programmes.
NIPER Raebareli | 23/02/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy